Document is current
Any future updates will be listed below
-
Authors
Jiang, Yangzi https://orcid.org/0000-0002-7475-3182
Tuan, Rocky S.
-
Funding
Funding for this research was provided by:
National Key Research and Development Program of China (2019YFA0111900)
Commonwealth of Pennsylvania Department of Health (SAP 4100050913)
Innovation and Technology Commission - Hong Kong (Health@InnoHK, CNRM, Health@InnoHK, CNRM)
Chinese University of Hong Kong (Lee Quo Wei, Lee Yick Hoi Lun Professorship in Tissue Engineering Regenerative Medicine)
- License Information
-
More Information
Article History
Received: 18 September 2022
Accepted: 31 May 2023
First Online: 14 June 2023
Declarations
:
: Adult human adult stem/progenitor cells were isolated from surgical waste of adipose, bone marrow, and articular cartilage tissue with approval from the Institutional Review Board (“<i>Stem cells for orthopaedic research”,</i> University of Pittsburgh and University of Washington, 2013) [], and The Chinese University of Hong Kong (“<i>Tissue bank for the osteoarthritis mechanism study</i>”, the Joint Chinese University of Hong Kong – New Territories East Cluster Clinical Research Ethics Committee, The Joint CUHK-NTEC CREC, Ref. No. 2019.078, 2019) with written informed consent obtained. At the time of collection, samples were de-identified and included in IRB-approved patient consent forms and have been approved for research use and publication.
: Not applicable.
: YJ, none. RST serves as one of the Editors-in-Chiefs of <i>Stem Cell Research & Therapy</i>. Rocky S Tuan was not involved in the peer review or decision making of this article.
